Article
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Vox sanguinis - 1 Jan 2017
Lin Y, Saskin A, Wells R A, Lenis M, Mamedov A, Callum J, Buckstein R
Abstract excerpt
BACKGROUND AND OBJECTIVES: Thirty to 80 per cent of patients with myelodysplastic syndromes (MDS) become transfusion-dependent and are at risk for red blood cell (RBC) alloimmunization. This study compared alloimmunization rates in transfusion-dependent patients with MDS at an institution with a policy of prophylactic antigen matching for RhCE and K (PAM) with those transfused at institutions without such a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.